A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 1994

Conditions
Pneumonia, Pneumocystis CariniiHIV Infections
Interventions
DRUG

Pentamidine isethionate

DRUG

Dapsone

Trial Locations (14)

10037

Harlem AIDS Treatment Group / Harlem Hosp Ctr, New York

10456

Bronx Lebanon Hosp Ctr, The Bronx

19899

Wilmington Hosp / Med Ctr of Delaware, Wilmington

20422

Veterans Administration Med Ctr / Regional AIDS Program, Washington D.C.

23298

Richmond AIDS Consortium, Richmond

46202

Wishard Hosp / Indiana Univ Hosp, Indianapolis

48201

Comprehensive AIDS Alliance of Detroit, Detroit

48202

Henry Ford Hosp, Detroit

60657

AIDS Research Alliance - Chicago, Chicago

70112

Louisiana Comm AIDS Rsch Prog / Tulane Univ Med, New Orleans

94110

Community Consortium of San Francisco, San Francisco

802044507

Denver CPCRA / Denver Public Hlth, Denver

972109951

Portland Veterans Adm Med Ctr / Rsch & Education Grp, Portland

071032842

North Jersey Community Research Initiative, Newark

All Listed Sponsors
collaborator

Jacobus Pharmaceutical

INDUSTRY

collaborator

Fujisawa Pharmaceutical Co

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH